These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6439013)

  • 1. Metabolic bone disease associated with total parenteral nutrition.
    Klein GL; Coburn JW
    Adv Nutr Res; 1984; 6():67-92. PubMed ID: 6439013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible role of vitamin D in the genesis of parenteral-nutrition-induced metabolic bone disease.
    Shike M; Sturtridge WC; Tam CS; Harrison JE; Jones G; Murray TM; Husdan H; Whitwell J; Wilson DR; Jeejeebhoy KN
    Ann Intern Med; 1981 Nov; 95(5):560-8. PubMed ID: 6794407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone disease associated with total parenteral nutrition.
    Klein GL; Targoff CM; Ament ME; Sherrard DJ; Bluestone R; Young JH; Norman AW; Coburn JW
    Lancet; 1980 Nov; 2(8203):1041-4. PubMed ID: 6107676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic bone disease in patients receiving long-term total parenteral nutrition.
    Shike M; Harrison JE; Sturtridge WC; Tam CS; Bobechko PE; Jones G; Murray TM; Jeejeebhoy KN
    Ann Intern Med; 1980 Mar; 92(3):343-50. PubMed ID: 6766694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of 1,25-dihydroxyvitamin D in children receiving parenteral nutrition with reduced aluminum content.
    Klein GL; Horst RL; Alfrey AC; Slatopolsky E
    J Pediatr Gastroenterol Nutr; 1985 Feb; 4(1):93-6. PubMed ID: 3920379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifactorial low remodeling bone disease during cyclic total parenteral nutrition.
    de Vernejoul MC; Messing B; Modrowski D; Bielakoff J; Buisine A; Miravet L
    J Clin Endocrinol Metab; 1985 Jan; 60(1):109-13. PubMed ID: 3917265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content.
    Vargas JH; Klein GL; Ament ME; Ott SM; Sherrard DJ; Horst RL; Berquist WE; Alfrey AC; Slatopolsky E; Coburn JW
    Am J Clin Nutr; 1988 Oct; 48(4):1070-8. PubMed ID: 3138907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone disease in prolonged parenteral nutrition: osteopenia without mineralization defect.
    Shike M; Shils ME; Heller A; Alcock N; Vigorita V; Brockman R; Holick MF; Lane J; Flombaum C
    Am J Clin Nutr; 1986 Jul; 44(1):89-98. PubMed ID: 3088971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced serum levels of 1 alpha,25-dihydroxyvitamin D during long-term total parenteral nutrition.
    Klein GL; Horst RL; Norman AW; Ament ME; Slatopolsky E; Coburn JW
    Ann Intern Med; 1981 May; 94(5):638-43. PubMed ID: 6786151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone and mineral status of patients beginning total parenteral nutrition.
    Epstein S; Traberg H; Levine G; McClintock R
    JPEN J Parenter Enteral Nutr; 1986; 10(3):263-4. PubMed ID: 3086583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium metabolism in children during long-term total parenteral nutrition: the influence of calcium, phosphorus, and vitamin D intakes.
    Larchet M; Garabédian M; Bourdeau A; Gorski AM; Goulet O; Ricour C
    J Pediatr Gastroenterol Nutr; 1991 Nov; 13(4):367-75. PubMed ID: 1779310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic bone disease of total parenteral nutrition.
    Klein GL
    Nutrition; 1998 Jan; 14(1):149-52. PubMed ID: 9437701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harry M. Vars Research Award. Increase in lumbar spine bone mineral content in patients on long-term parenteral nutrition without vitamin D supplementation.
    Verhage AH; Cheong WK; Allard JP; Jeejeebhoy KN
    JPEN J Parenter Enteral Nutr; 1995; 19(6):431-6. PubMed ID: 8748356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total parenteral nutrition and its effects on bone metabolism.
    Klein GL; Coburn JW
    Crit Rev Clin Lab Sci; 1994; 31(2):135-67. PubMed ID: 7917007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse metabolic consequences of total parenteral nutrition.
    Klein GL; Rivera D
    Cancer; 1985 Jan; 55(1 Suppl):305-8. PubMed ID: 3917364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic bone disease in home total parenteral nutrition.
    McCullough ML; Hsu N
    J Am Diet Assoc; 1987 Jul; 87(7):915-20. PubMed ID: 3110249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocalcemia complicating deferoxamine therapy in an infant with parenteral nutrition-associated aluminum overload: evidence for a role of aluminum in the bone disease of infants.
    Klein GL; Snodgrass WR; Griffin MP; Miller NL; Alfrey AC
    J Pediatr Gastroenterol Nutr; 1989 Oct; 9(3):400-3. PubMed ID: 2515268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition.
    Ott SM; Maloney NA; Klein GL; Alfrey AC; Ament ME; Coburn JW; Sherrard DJ
    Ann Intern Med; 1983 Jun; 98(6):910-4. PubMed ID: 6407375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic bone disease in a patient on long-term total parenteral nutrition: a case report with review of literature.
    Seligman JV; Basi SS; Deitel M; Bayley TA; Khanna RK
    JPEN J Parenter Enteral Nutr; 1984; 8(6):722-7. PubMed ID: 6441020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.